1. Home
  2. PFSI vs GRFS Comparison

PFSI vs GRFS Comparison

Compare PFSI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSI
  • GRFS
  • Stock Information
  • Founded
  • PFSI 2008
  • GRFS 1940
  • Country
  • PFSI United States
  • GRFS Spain
  • Employees
  • PFSI N/A
  • GRFS N/A
  • Industry
  • PFSI Finance: Consumer Services
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFSI Finance
  • GRFS Health Care
  • Exchange
  • PFSI Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • PFSI 6.9B
  • GRFS 6.6B
  • IPO Year
  • PFSI 2013
  • GRFS 2006
  • Fundamental
  • Price
  • PFSI $129.47
  • GRFS $9.38
  • Analyst Decision
  • PFSI Buy
  • GRFS Hold
  • Analyst Count
  • PFSI 6
  • GRFS 1
  • Target Price
  • PFSI $138.67
  • GRFS $10.30
  • AVG Volume (30 Days)
  • PFSI 422.6K
  • GRFS 486.3K
  • Earning Date
  • PFSI 10-21-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • PFSI 0.92%
  • GRFS 1.52%
  • EPS Growth
  • PFSI 189.98
  • GRFS 132.60
  • EPS
  • PFSI 9.29
  • GRFS 0.53
  • Revenue
  • PFSI $2,965,619,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • PFSI $6.07
  • GRFS $5.46
  • Revenue Next Year
  • PFSI $24.34
  • GRFS $6.69
  • P/E Ratio
  • PFSI $14.01
  • GRFS $23.09
  • Revenue Growth
  • PFSI 47.97
  • GRFS 9.32
  • 52 Week Low
  • PFSI $85.74
  • GRFS $6.19
  • 52 Week High
  • PFSI $134.56
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • PFSI 62.35
  • GRFS 41.18
  • Support Level
  • PFSI $128.68
  • GRFS $9.24
  • Resistance Level
  • PFSI $134.08
  • GRFS $9.59
  • Average True Range (ATR)
  • PFSI 3.83
  • GRFS 0.19
  • MACD
  • PFSI 1.00
  • GRFS -0.01
  • Stochastic Oscillator
  • PFSI 74.48
  • GRFS 25.00

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: